These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34333937)

  • 1. [Role of Claudin-1 on diagnostic cut-off value and multiple tests in patients with papillary thyroid carcinoma].
    Hou WD; Ding HX; Li HM; Wang JH; Liu YF
    Zhonghua Yi Xue Za Zhi; 2021 Jul; 101(28):2233-2237. PubMed ID: 34333937
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic utility of CK19 and CD56 in the differentiation of thyroid papillary carcinoma from its mimics.
    Abouhashem NS; Talaat SM
    Pathol Res Pract; 2017 May; 213(5):509-517. PubMed ID: 28214214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the diagnostic value of emerin and CD56 in papillary thyroid carcinoma - an immunohistochemical study.
    Abdou AG; Abdelwahed M; Said A; Taie DM; Fahmy S
    J Immunoassay Immunochem; 2018; 39(5):521-537. PubMed ID: 30188764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of tumor markers in the diagnosis of papillary thyroid carcinoma alone and in combination.
    Ma H; Xu S; Yan J; Zhang C; Qin S; Wang X; Li N
    Pol J Pathol; 2014 Oct; 65(3):202-9. PubMed ID: 25372417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Value of Serum Cytokeratin 18, Carcinoembryonic Antigen, and Thyroglobulin in Patients with Papillary Thyroid Carcinoma.
    Yan G; Zhou Y; Wu H; Xun H
    Clin Lab; 2021 Feb; 67(2):. PubMed ID: 33616340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of CD56 immunohistochemistry in thyroid lesions.
    Pyo JS; Kim DH; Yang J
    Int J Biol Markers; 2018 May; 33(2):161-167. PubMed ID: 29799356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential diagnostic utility of CD56 and claudin-1 in papillary thyroid carcinoma and solitary follicular thyroid nodules.
    Abd El Atti RM; Shash LS
    J Egypt Natl Canc Inst; 2012 Dec; 24(4):175-84. PubMed ID: 23159288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic value of TROP-2, SLP-2 and CD56 expression in papillary thyroid carcinoma.
    Yang X; Hu Y; Shi H; Zhang C; Wang Z; Liu X; Chen H; Zhang L; Cui D
    Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2127-2134. PubMed ID: 29951933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of chemokine CXC motif ligand 12 as a novel diagnostic marker in preoperative fine-needle aspiration biopsy for papillary thyroid carcinoma.
    Jung YY; Park IA; Kim MA; Min HS; Won JK; Ryu HS
    Acta Cytol; 2013; 57(5):447-54. PubMed ID: 24021782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma.
    Tan A; Etit D; Bayol U; Altinel D; Tan S
    Ann Diagn Pathol; 2011 Apr; 15(2):108-16. PubMed ID: 21315633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Diagnostic Accuracy Based on CLDN10, HMGA2, and LAMB3 Transcripts in Papillary Thyroid Carcinoma.
    Barros-Filho MC; Marchi FA; Pinto CA; Rogatto SR; Kowalski LP
    J Clin Endocrinol Metab; 2015 Jun; 100(6):E890-9. PubMed ID: 25867809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of phosphatidylinositol 3-kinase regulatory subunit alpha, activator protein-1, and programmed cell death 4 in diagnosis of papillary thyroid carcinoma.
    Chen X; Wu W; Chen X; Gong X
    Tumour Biol; 2016 May; 37(5):6519-26. PubMed ID: 26637226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The difference expression and diagnostic value of RPL5 in papillary thyroid carcinoma of children and adults].
    Jin YQ; Wang SC; Tai J; Zhang J; Chen F; Shi J; Yu YB; Yang YR; Ren HM; Geng D; Liu YH; Guo YL; Ni X
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Nov; 52(11):830-834. PubMed ID: 29141292
    [No Abstract]   [Full Text] [Related]  

  • 14. Circulating epithelial cells as potential biomarkers for detection of recurrence in patients of papillary thyroid carcinoma with positive serum anti-thyroglobulin antibody.
    Li YR; Tseng CP; Hsu HL; Lin HC; Chen YA; Chen ST; Liou MJ; Lin JD
    Clin Chim Acta; 2018 Feb; 477():74-80. PubMed ID: 29229463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The absence of CD56 expression can differentiate papillary thyroid carcinoma from other thyroid lesions.
    Golu I; Vlad MM; Dema A; Moleriu LC; Tudor A; Iacob M; Popa O; Cornianu M
    Indian J Pathol Microbiol; 2017; 60(2):161-166. PubMed ID: 28631628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic significance of elevated expression of HBME-1 in papillary thyroid carcinoma.
    Chen YJ; Zhao RM; Zhao Q; Li BY; Ma QY; Li X; Chen X
    Tumour Biol; 2016 Jul; 37(7):8715-20. PubMed ID: 26738867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of CD56 and nm23 markers in papillary thyroid carcinoma.
    Shahebrahimi K; Madani SH; Fazaeli AR; Khazaei S; Kanani M; Keshavarz A
    Indian J Pathol Microbiol; 2013; 56(1):2-5. PubMed ID: 23924549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cd56 and e-cadherin expression in the differential diagnosis of papillary thyroid carcinoma and suspected follicular-patterned lesions of the thyroid: the prognostic importance of e-cadherin.
    Ceyran AB; Şenol S; Şimşek BÇ; Sağıroğlu J; Aydın A
    Int J Clin Exp Pathol; 2015; 8(4):3670-80. PubMed ID: 26097548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of HBME-1, CD56, Galectin-3 and Cytokeratin-19 in papillary thyroid carcinomas and thyroid tumors of uncertain malignant potential.
    Nechifor-Boilă A; Cătană R; Loghin A; Radu TG; Borda A
    Rom J Morphol Embryol; 2014; 55(1):49-56. PubMed ID: 24715165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical study of papillary thyroid carcinoma and possible papillary thyroid carcinoma-related benign thyroid nodules.
    Mai KT; Ford JC; Yazdi HM; Perkins DG; Commons AS
    Pathol Res Pract; 2000; 196(8):533-40. PubMed ID: 10982016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.